Nephrocare Health Services: Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Nephrocare Health Services (NEPHROPLUS) filed a disclosure titled "Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company". The company is valued at about ₹6,166 crore.
What happened
Nephrocare Health Services (NEPHROPLUS) filed a disclosure with the exchanges on 2 November 2026 at 10:17 PM titled "Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company".
Company snapshot
Nephrocare Health Services is a small-cap company in the Healthcare sector, with a market value of about ₹6,166 crore.
The stock last traded at ₹614.6, against a 52-week range of ₹446–₹781.5 (21.4% below the high).
Before this filing the shares had moved −7.4% over the month and −9.8% over three months. Average daily turnover over the last 20 sessions was about ₹10.06 crore.
Promoters held 63.85% at the end of Q1 FY27. Foreign institutions owned 8.78% and domestic institutions 9.05%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q3 FY26 | 260 | 32.2 | 3.43 |
| Q4 FY26 | 266 | 30.4 | 3.03 |
| Q1 FY27 | 282 | 32 | 3.19 |
What history shows
BCEIE's records show 1 previous litigation filing from the company since May 2026.
Across 21 similar disclosures by other Healthcare companies, shares moved −0.5% on average the next day and −0.5% over five days; 33% of them rose the next day.
Market-wide, 627 litigation filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 36% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- 3 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.